Abstract
Objectives
Medialization thyroplasty (MT) using various implants has been employed as a corrective procedure for unilateral vocal fold paralysis (UVFP). A newly developed APrevent® vocal implant system (VOIS) offers an innovative solution with a finely adjustable design. This study aimed to investigate the long-term functional voice outcomes and benefits of postoperative adjustments in patients receiving MT using the VOIS-implant.
Methods
This is a prospective case series study at single tertiary medical center. Fourteen adult patients diagnosed with UVFP received MT with the VOIS implant and were followed up for more than 1 year. Implant adjustment procedure by injecting 0.9% physiological saline solution was performed both during and after the surgery to optimize glottal closure and voice quality. Objective voice outcomes and acoustic parameters were assessed preoperatively and postoperatively at various timepoints.
Results
Thirteen patients (93%) received intraoperative balloon adjustment, ranging from 0.05to 0.12 ml. Four patients underwent adjustments postoperatively and exhibited a positive trend towards immediately improving acoustic voice quality. Our long-term results demonstrated a notable improvement after the surgery in voice quality, with significant decreases in VHI-30 and improvements in perceptual parameters of GRBAS scale, acoustic measures such as jitter and signal-to-noise ratio (p < 0.001) and cepstral peak prominence smoothed in sustained vowel and short sentences. The voice outcomes remained stable more than 1 year follow-up.
Conclusions
Overall, MT with VOIS implantation provides a favorable long-term outcomes and stability in voice quality for patients with UVFP and also an effective tool for postoperative adjustment without major revision surgeries.
Similar content being viewed by others
Data Availability
The data that support the findings of this study are available on request from the corresponding author.
References
Siu J, Tam S, Fung K (2016) A comparison of outcomes in interventions for unilateral vocal fold paralysis: a systematic review. Laryngoscope 126(7):1616–1624. https://doi.org/10.1002/lary.25739
Isshiki N, Morita H, Okamura H, Hiramoto M (1974) Thyroplasty as a new phonosurgical technique. Acta Otolaryngol 78(5–6):451–457. https://doi.org/10.3109/00016487409126379
Crolley VE, Gibbins N (2017) One hundred years of external approach medialisation thyroplasty. J Laryngol Otol 131(3):202–208. https://doi.org/10.1017/S0022215116010033
Hajioff D, Rattenbury H, Carrie S, Carding P, Wilson J (2000) The effect of Isshiki type 1 thyroplasty on quality of life and vocal performance. Clin Otolaryngol Allied Sci 25(5):418–422. https://doi.org/10.1046/j.1365-2273.2000.00395.x
Storck C, Brockmann M, Schnellmann E, Stoeckli SJ, Schmid S (2007) Functional outcome of vocal fold medialization thyroplasty with a hydroxyapatite implant. Laryngoscope 117(6):1118–1122. https://doi.org/10.1097/MLG.0b013e318041f6ed
Suehiro A, Hirano S, Kishimoto Y, Tanaka S, Ford CN (2009) Comparative study of vocal outcomes with silicone versus Gore-Tex thyroplasty. Ann Otol Rhinol Laryngol 118(6):405–408. https://doi.org/10.1177/000348940911800602
Friedrich G (1999) Titanium vocal fold medializing implant: introducing a novel implant system for external vocal fold medialization. Ann Otol Rhinol Laryngol 108(1):79–86. https://doi.org/10.1177/000348949910800112
van Ardenne N, Vanderwegen J, Van Nuffelen G, De Bodt M, Van de Heyning P (2011) Medialization thyroplasty: vocal outcome of silicone and titanium implant. Eur Arch Otorhinolaryngol 268(1):101–107. https://doi.org/10.1007/s00405-010-1327-7
Daniero JJ, Garrett CG, Francis DO (2014) Framework surgery for treatment of unilateral vocal fold paralysis. Curr Otorhinolaryngol Rep 2(2):119–130. https://doi.org/10.1007/s40136-014-0044-y
Mousli A (2014) Anwendung der digitalen Volumen-Tomographie (DVT) zur Planung einer Thyreoplastik-Operation (Doctoral dissertation, Staats-und Universitätsbibliothek Hamburg Carl von Ossietzky)
Rosen CA (1998) Complications of phonosurgery: results of a national survey. Laryngoscope 108(11 Pt 1):1697–1703. https://doi.org/10.1097/00005537-199811000-00020
Laccourreye O, Ménard M (2011) Complications of thyroplasty type I with montgomery implant. Otolaryngol Head Neck Surg 145(S2):P79–P79. https://doi.org/10.1177/0194599811416318a121
Anderson TD, Spiegel JR, Sataloff RT (2003) Thyroplasty revisions: frequency and predictive factors. J Voice 17(3):442–448. https://doi.org/10.1067/s0892-1997(03)00080-8
Lundeberg MR, Flint PW, Purcell LL, McMurray JS, Cummings CW (2011) Revision medialization thyroplasty with hydroxylapatite implants. Laryngoscope 121(5):999–1002. https://doi.org/10.1002/lary.21455
Isshiki N, Tanabe M, Sawada M (1978) Arytenoid adduction for unilateral vocal cord paralysis. Arch Otolaryngol 104(10):555–558. https://doi.org/10.1001/archotol.1978.00790100009002
Liu C, Qiu Y, Zhang X, Liu Y, Li G, Huang D (2021) Modified arytenoid adduction operation for the treatment of unilateral vocal fold paralysis. ORL 84(3):205–210. https://doi.org/10.1159/000517561
Abraham MT, Gonen M, Kraus DH (2001) Complications of type I thyroplasty and arytenoid adduction. Laryngoscope 111(8):1322–1329. https://doi.org/10.1097/00005537-200108000-00003
Ho GM, Rast J, Hsieh LC, Böttcher A, Meng S, Reissig LF, Tzou CH, Hess MM, Schneider-Stickler B, Jiang J, Lai YT, Yuan SP, Wang YP, Geyer SH, Weninger WJ (2023) Pre-clinical evaluation of APrevent® VOIS for unilateral vocal fold paralysis medialization. Laryngoscope Investig Otolaryngol 8(3):712–719. https://doi.org/10.1002/lio2.1059
Ho G-Y, Leonhard M, Denk-Linnert D-M, Schneider-Stickler B (2020) Pre- and intraoperative acoustic and functional assessment of the novel APrevent® VOIS implant during routine medialization thyroplasty. Eur Arch Otorhinolaryngol 277(3):809–817. https://doi.org/10.1007/s00405-019-05756-3
Hsieh LC, Chen CK, Chang CW, Leu YS, Ho GM (2022) Preliminary clinical outcomes of VOIS-implant in patients with unilateral vocal fold paralysis. Laryngoscope 132(8):1622–1629. https://doi.org/10.1002/lary.29958
Jacobson BH, Johnson A, Grywalski C, Silbergleit A, Jacobson G, Benninger MS, Newman CW (1997) The voice handicap index (VHI): development and validation. Am J Speech Lang Pathol 6:66–70. https://doi.org/10.1044/1058-0360.0603.66
Fu S, Theodoros DG, Ward EC (2015) Intensive versus traditional voice therapy for vocal nodules: perceptual, physiological, acoustic and aerodynamic changes. J Voice 29(2):260.e231–244. https://doi.org/10.1016/j.jvoice.2014.06.005
Heman-Ackah YD, Heuer RJ, Michael DD, Ostrowski R, Horman M, Baroody MM, Hillenbrand J, Sataloff RT (2003) Cepstral peak prominence: a more reliable measure of dysphonia. Ann Otol Rhinol Laryngol 112(4):324–333. https://doi.org/10.1177/000348940311200406
Stemple JC, Roy N, Klaben BK (2018) Clinical voice pathology: theory and management. Plural Publishing, San Diego
Boone DR, McFarlane SC, Von Berg SL, Zraick RI (2005) The voice and voice therapy. Pearson, Indianapolis
Young VN, Zullo TG, Rosen CA (2010) Analysis of laryngeal framework surgery: 10-year follow-up to a national survey. Laryngoscope 120(8):1602–1608. https://doi.org/10.1002/lary.21004
Hoffman MR, Witt RE, McCulloch TM, Jiang JJ (2011) Preliminary investigation of adjustable balloon implant for type I thyroplasty. Laryngoscope 121(4):793–800. https://doi.org/10.1002/lary.21431
Devos M, Schultz P, Guilleré F, Debry C (2010) Thyroplasty for unilateral vocal fold paralysis using an adjustable implant in porous titanium. Eur Ann Otorhinolaryngol Head Neck Dis 127(6):204–212. https://doi.org/10.1016/j.anorl.2010.08.001
Oguz H, Demirci M, Safak MA, Arslan N, Islam A, Kargin S (2007) Effects of unilateral vocal cord paralysis on objective voice measures obtained by Praat. Eur Arch Otorhinolaryngol 264(3):257–261. https://doi.org/10.1007/s00405-006-0179-7
Balasubramanium RK, Bhat JS, Fahim S 3rd, Raju R 3rd (2011) Cepstral analysis of voice in unilateral adductor vocal fold palsy. J Voice 25(3):326–329. https://doi.org/10.1016/j.jvoice.2009.12.010
Lopes LW, Sousa E, Silva A, Silva IMD, Paiva MAA, Vieira VJD, Almeida AA (2019) Cepstral measures in the assessment of severity of voice disorders. Codas 31(4):e20180175. https://doi.org/10.1590/2317-1782/20182018175. (Medidas cepstrais na avaliação da intensidade do desvio vocal)
Jannetts S, Lowit A (2014) Cepstral analysis of hypokinetic and ataxic voices: correlations with perceptual and other acoustic measures. J Voice 28(6):673–680. https://doi.org/10.1016/j.jvoice.2014.01.013
Halberstam B (2004) Acoustic and perceptual parameters relating to connected speech are more reliable measures of hoarseness than parameters relating to sustained vowels. ORL J Otorhinolaryngol Relat Spec 66(2):70–73. https://doi.org/10.1159/000077798
Tsai MS, Yang MY, Chang GH, Tsai YT, Lin MH, Hsu CM (2017) Autologous thyroid cartilage graft implantation in medialization laryngoplasty: a modified approach for treating unilateral vocal fold paralysis. Sci Rep 7(1):4790. https://doi.org/10.1038/s41598-017-05024-6
Liao LJ, Wang CT (2022) Management of unilateral vocal fold paralysis after thyroid surgery with injection laryngoplasty: state of art review. Front Surg 9:876228. https://doi.org/10.3389/fsurg.2022.876228
Funding
This work was supported by the National Science and Technology Council (Taiwan) under Grant No. MOST 111-2314-B-715-012-.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by P-KH, Y-HY and L-CH. The first draft of the manuscript was written by P-KH and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
Author Guan-Min Ho declares to be the inventor of the VOIS-Implant and standardized VOIS-Implantation procedure. Other authors declare that they have no conflict of interest. The authors have no other funding financial relationships, or conflicts of interest to disclose.
Ethics approval
This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the institutional review board in Mackay Memorial Hospital (IRB no: 21MMHIS164e).
Consent to participate and consent to publish
Written informed consent was obtained from the patient for their anonymized information to be published in this article.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Huang, PK., Chen, CK., Yu, YH. et al. Long-term voice outcomes of medialization thyroplasty with adjustable implant for unilateral vocal fold paralysis. Eur Arch Otorhinolaryngol 281, 1371–1378 (2024). https://doi.org/10.1007/s00405-023-08367-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-023-08367-1